Literature DB >> 12222964

Proinsulin C-peptide and its analogues induce intracellular Ca2+ increases in human renal tubular cells.

J Shafqat1, L Juntti-Berggren, Z Zhong, K Ekberg, M Köhler, P O Berggren, J Johansson, J Wahren, H Jörnvall.   

Abstract

Based on the findings that proinsulin C-peptide binds specifically to cell membranes, we investigated the effects of C-peptide and related molecules on the intracellular Ca2+ concentration ([Ca2+]i) in human renal tubular cells using the indicator fura-2/AM. The results show that human C-peptide and its C-terminal pentapeptide (positions 27-31, EGSLQ), but not the des (27-31) C-peptide or randomly scrambled C-peptide, elicit a transient increase in [Ca2+]i. Rat C-peptide and rat C-terminal pentapeptide also induce a [Ca2+]i response in human tubular cells, while a human pentapeptide analogue with Ala at position 1 gives no [Ca2+]i response, and those with Ala at positions 2-5 induce responses with different amplitudes. These results define a species cross-reactivity for C-peptide and demonstrate the importance of Glu at position 1 of the pentapeptide. Preincubation of cells with pertussis toxin abolishes the effect on [Ca2+]i by both C-peptide and the pentapeptide. These results are compatible with previous data on C-peptide binding to cells and activation of Na-,K+ATPase. Combined, all data show that C-peptide is a bioactive peptide and suggest that it elicits changes in [Ca2+]i via G-protein-coupled pathways, giving downstream enzyme effects.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12222964     DOI: 10.1007/s00018-002-8496-5

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  15 in total

1.  Potent activation of multiple signalling pathways by C-peptide in opossum kidney proximal tubular cells.

Authors:  N M Al-Rasheed; F Meakin; E L Royal; A J Lewington; J Brown; G B Willars; N J Brunskill
Journal:  Diabetologia       Date:  2004-05-26       Impact factor: 10.122

2.  C-peptide is a bioactive peptide.

Authors:  J Wahren; K Ekberg; H Jörnvall
Journal:  Diabetologia       Date:  2007-01-18       Impact factor: 10.122

3.  C-peptide stimulates ERK1/2 and JNK MAP kinases via activation of protein kinase C in human renal tubular cells.

Authors:  Z Zhong; A Davidescu; I Ehrén; K Ekberg; H Jörnvall; J Wahren; A V Chibalin
Journal:  Diabetologia       Date:  2004-12-29       Impact factor: 10.122

4.  Proinsulin C-peptide elicits disaggregation of insulin resulting in enhanced physiological insulin effects.

Authors:  J Shafqat; E Melles; K Sigmundsson; B-L Johansson; K Ekberg; G Alvelius; M Henriksson; J Johansson; J Wahren; H Jörnvall
Journal:  Cell Mol Life Sci       Date:  2006-08       Impact factor: 9.261

5.  Proinsulin C-peptide increases nitric oxide production by enhancing mitogen-activated protein-kinase-dependent transcription of endothelial nitric oxide synthase in aortic endothelial cells of Wistar rats.

Authors:  T Kitamura; K Kimura; K Makondo; D T Furuya; M Suzuki; T Yoshida; M Saito
Journal:  Diabetologia       Date:  2003-10-30       Impact factor: 10.122

6.  Molecular effects of C-Peptide in microvascular blood flow regulation.

Authors:  Thomas Forst; Thomas Hach; Thomas Kunt; Matthias M Weber; Andreas Pfützner
Journal:  Rev Diabet Stud       Date:  2009-11-10

Review 7.  The clinical potential of C-peptide replacement in type 1 diabetes.

Authors:  John Wahren; Asa Kallas; Anders A F Sima
Journal:  Diabetes       Date:  2012-04       Impact factor: 9.461

8.  C-Peptide reduces mitochondrial superoxide generation by restoring complex I activity in high glucose-exposed renal microvascular endothelial cells.

Authors:  Himani Vejandla; John M Hollander; Anand Kothur; Robert W Brock
Journal:  ISRN Endocrinol       Date:  2012-06-21

9.  The role of insulin C-peptide in the coevolution analyses of the insulin signaling pathway: a hint for its functions.

Authors:  Shuai Wang; Wei Wei; Yadong Zheng; Junling Hou; Yongxi Dou; Shaohua Zhang; Xuenong Luo; Xuepeng Cai
Journal:  PLoS One       Date:  2012-12-27       Impact factor: 3.240

10.  C-peptide and its C-terminal fragments improve erythrocyte deformability in type 1 diabetes patients.

Authors:  Thomas Hach; Thomas Forst; Thomas Kunt; Karin Ekberg; Andreas Pfützner; John Wahren
Journal:  Exp Diabetes Res       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.